Delivery Order SPE2DB25D3005-SPE2DB25FQDGS
Award Date
3/13/25
Potential Completion Date
3/14/25
Potential Value
$4.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $7,275.84, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, for the provision of ADBRY 300 MG/2 ML AUTOINJECTOR 2ML medical supplies. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $5,434.89, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ADBRY 300 MG/2 ML AUTOINJECTOR 2ML, a medical product. The contract has an ultimate completion date of March 3, 2025 and is a Firm Fixed Price Delivery Order. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of an autoinjector product (ADBRY 300 MG/2 ML AUTOINJECTOR 2ML) with a ceiling value of $19,912.70 and a period of performance through February 2025. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,126.62 Firm Fixed Price Delivery Order covers the supply of ADBRY 150 MG/ML SYRINGE to support military healthcare programs. The contract is not set aside and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,041.76 contract is for the supply of ADBRY 300 MG/2 ML AUTOINJECTOR 2ML, a pharmaceutical product. The contract has a period of performance through February 28, 2025. This appears to be a standalone contract award and not associated with a larger contract vehicle. The contract does not have a set-aside...
This federal contract award, valued at $4,301.64, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of the pharmaceutical product ADBRY 150 MG/ML SYRINGEML, with a completion date of May 3, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. government, holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,525.37, is for the delivery of ADBRY 150 MG/ML SYRINGEML, a pharmaceutical product. This is a Firm Fixed Price delivery order contract with an ultimate completion date of May 9, 2023. The contract is not designated with a set-aside, indicating open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,431.99 firm fixed-price delivery order is for 4562267467 ABRYSVO VIAL WITH DILUENTS, with a completion date of September 22, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,435.17 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies, including...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,606.50 firm fixed-price delivery order contract has an ultimate completion date of January 27, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...